Outcomes of Allogeneic Stem Cell Transplant (allo-SCT) Recipients in the Era of Newer Antifungal Agents
Year: 2014
Type: article
Study design: Observational Study
Abstract: Data from large patient samples evaluating the magnitude of benefit with the newer anti-fungal agents are lacking. We have analyzed the Nationwide Inpt Sample (NIS) database to evaluate the trends in the incidence of fungal infections and to evaluate the potential impact of newer anti-fungal agents on in-hospital mortality among allo-SCT recipients. Our data suggests that the use of newer anti-fungal agents has an impact on the survivability of fungal infections in the setting of allo-SCT.
Institutions: Emory University, Winship Cancer Institute
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $350
OpenAlex ID: W2005872149
